09 Mar 23:20
by Xuhui Zheng
Infect Immun. 2022 Mar 8:e0005622. doi: 10.1128/iai.00056-22. Online ahead of print.
ABSTRACT
Infections caused by the Gram-positive bacterium Staphylococcus aureus remain a significant health threat globally. The production of bicomponent pore-forming leukocidins plays an important role in S. aureus pathogenesis. Transcriptionally, these toxins are primarily regulated by the Sae and Agr regulatory systems. However, the posttranslational regulation of these toxins is largely unexplored. In particular, one of the leukocidins, LukAB, has been shown to be both secreted into the extracellular milieu and associated with the bacterial cell envelope. Here, we report that a major cell wall hydrolase, autolysin (Atl), controls the sorting of LukAB from the cell envelope to the extracellular milieu, an effect independent of transcriptional regulation. By influencing the sorting of LukAB, Atl modulates S. aureus cytotoxicity toward primary human neutrophils. Mechanistically, we found that the reduction in peptidoglycan cleavage and increased LukAB secretion in the atl mutant can be reversed through the supplementation of exogenous mutanolysin. Altogether, our study revealed that the cell wall hydrolase activity of Atl and the cleavage of peptidoglycan play an important role in controlling the sorting of S. aureus toxins during secretion.
PMID:35258336 | DOI:10.1128/iai.00056-22
08 Mar 21:02
Publication date: 31 March 2022
Source: Cell, Volume 185, Issue 7
Author(s): Xiaozhe Xiong, Songhai Tian, Pan Yang, Francois Lebreton, Huan Bao, Kuanwei Sheng, Linxiang Yin, Pengsheng Chen, Jie Zhang, Wanshu Qi, Jianbin Ruan, Hao Wu, Hong Chen, David T. Breault, Hao Wu, Ashlee M. Earl, Michael S. Gilmore, Jonathan Abraham, Min Dong
08 Mar 19:32
by Ignacio Moya-Ramírez, Pavlos Kotidis, Masue Marbiah, Juhyun Kim, Cleo Kontoravdi, and Karen Polizzi

ACS Synthetic Biology
DOI: 10.1021/acssynbio.1c00577
08 Mar 19:32
by Boon Lim, Yutong Yin, Hua Ye, Zhanfeng Cui, Antonis Papachristodoulou, and Wei E. Huang

ACS Synthetic Biology
DOI: 10.1021/acssynbio.1c00631
03 Mar 23:18
by Xingye Yang, Mengzhen Li, Xiaojun Qin, Siyu Tan, Lupei Du, Chunhong Ma, and Minyong Li

Journal of the American Chemical Society
DOI: 10.1021/jacs.1c11498
03 Mar 22:59
by Pierre Adumeau, René Raavé, Milou Boswinkel, Sandra Heskamp, Hans J. C. T. Wessels, Alain J. van Gool, Mathieu Moreau, Claire Bernhard, Laurène Da Costa, Victor Goncalves, and Franck Denat

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.2c00049
28 Feb 21:29
by Kurumi Taniguchi
Diseases. 2022 Jan 31;10(1):9. doi: 10.3390/diseases10010009.
ABSTRACT
D-amino acids may play key roles for specific physiological functions in different organs including the brain. Importantly, D-amino acids have been detected in several neurological disorders such as schizophrenia, amyotrophic lateral sclerosis, and age-related disorders, reflecting the disease conditions. Relationships between D-amino acids and neurophysiology may involve the significant contribution of D-Serine or D-Aspartate to the synaptic function, including neurotransmission and synaptic plasticity. Gut-microbiota could play important roles in the brain-function, since bacteria in the gut provide a significant contribution to the host pool of D-amino acids. In addition, the alteration of the composition of the gut microbiota might lead to schizophrenia. Furthermore, D-amino acids are known as a physiologically active substance, constituting useful biomarkers of several brain disorders including schizophrenia. In this review, we wish to provide an outline of the roles of D-amino acids in brain health and neuropsychiatric disorders with a focus on schizophrenia, which may shed light on some of the superior diagnoses and/or treatments of schizophrenia.
PMID:35225861 | PMC:PMC8883943 | DOI:10.3390/diseases10010009
28 Feb 15:02
by George Vere
Biomolecules. 2022 Feb 12;12(2):300. doi: 10.3390/biom12020300.
ABSTRACT
Ubiquitylation and ISGylation are protein post-translational modifications (PTMs) and two of the main events involved in the activation of pattern recognition receptor (PRRs) signals allowing the host defense response to viruses. As with similar viruses, SARS-CoV-2, the virus causing COVID-19, hijacks these pathways by removing ubiquitin and/or ISG15 from proteins using a protease called PLpro, but also by interacting with enzymes involved in ubiquitin/ISG15 machinery. These enable viral replication and avoidance of the host immune system. In this review, we highlight potential points of therapeutic intervention in ubiquitin/ISG15 pathways involved in key host-pathogen interactions, such as PLpro, USP18, TRIM25, CYLD, A20, and others that could be targeted for the treatment of COVID-19, and which may prove effective in combatting current and future vaccine-resistant variants of the disease.
PMID:35204803 | DOI:10.3390/biom12020300
28 Feb 13:57
by Nicholas J Rettko
ACS Chem Biol. 2022 Feb 25. doi: 10.1021/acschembio.1c00808. Online ahead of print.
ABSTRACT
Senescent cells undergo a permanent cell cycle arrest and drive a host of age-related pathologies. Recent transgenic mouse models indicate that removing cells expressing the senescence marker p16Ink4a (p16) can increase median lifespan and delay the onset of many aging phenotypes. However, identifying and eliminating native human cells expressing p16 has remained a challenge. We hypothesize that senescent cells display peptides derived from p16 in major histocompatibility complex (MHC)-peptide complexes on the cell surface that could serve as targetable antigens for antibody-based biologics. Using Fab-phage display technology, we generated antibodies that bind to a p16 MHC-peptide complex from the human leukocyte antigen (HLA) allele HLA-B*35:01. When converted to single-chain Fab chimeric antigen receptor (CAR) constructs, these antibodies can recognize naturally presented p16 MHC-peptide complexes on the surface of cells and activate Jurkat cells. Furthermore, we developed antibodies against predicted p16 MHC-peptide complexes for HLA-A*02:01 that specifically recognize their respective antigen on the surface of cells. These tools establish a platform to survey the surface of senescent cells and provide a potential novel senolytic strategy.
PMID:35212540 | DOI:10.1021/acschembio.1c00808
28 Feb 13:57
by Liang Rong
J Mol Biol. 2022 Feb 23:167513. doi: 10.1016/j.jmb.2022.167513. Online ahead of print.
ABSTRACT
We have previously developed a universal chimeric antigen receptor (CAR), which recognizes dinitrophenyl (DNP) and can redirect T and NK cells to target cancer and HIV antigens using DNP-conjugated antibodies as adaptor molecules. However, the DNP-antibody conjugates are generated by random modification, which may not be optimal for this modular system. Here, we report the development of enhanced adaptor molecules by site-specific DNP modification. We use the genetic code expansion technology to generate single-chain fragment variable (scFv) antibodies with site-specific DNP. We compare four anti-CD19 scFv mutants and find that the one with DNP at the flexible peptide linker between VH and VL is the most effective in redirecting anti-DNP CAR-T cells against CD19+ cells. The other three mutants are ineffective in doing so due to reduced DNP exposure or abrogated CD19 binding. We also use the anti-CD22 scFv as another model adaptor molecule and again find that the peptide linker is ideal for DNP derivatization. Our approach can potentially be used to design enhanced adaptor molecules to redirect the DNP-mediated universal CAR against other tumor antigens.
PMID:35218770 | DOI:10.1016/j.jmb.2022.167513
25 Feb 19:02
by Basanta Dhodary
Microorganisms. 2022 Jan 24;10(2):264. doi: 10.3390/microorganisms10020264.
ABSTRACT
Pseudomonas aeruginosa is a common, opportunistic bacterial pathogen among patients with cystic fibrosis, asthma, and chronic obstructive pulmonary disease. During the course of these diseases, l-ornithine, a non-proteinogenic amino acid, becomes more abundant. P. aeruginosa is chemotactic towards other proteinogenic amino acids. Here, we evaluated the chemotaxis response of P. aeruginosa towards l-ornithine. Our results show that l-ornithine serves as a chemoattractant for several strains of P. aeruginosa, including clinical isolates, and that the chemoreceptors involved in P. aeruginosa PAO1 are PctA and PctB. It seems likely that P. aeruginosa's chemotactic response to l-ornithine might be a common feature and thus could potentially contribute to pathogenesis processes during colonization and infection scenarios.
PMID:35208720 | DOI:10.3390/microorganisms10020264
25 Feb 18:13
by David Goyard
RSC Med Chem. 2021 Nov 9;13(1):72-78. doi: 10.1039/d1md00262g. eCollection 2022 Jan 27.
ABSTRACT
The recruitment of antibody naturally present in human blood stream at the surface of cancer cells have been proved a promising immunotherapeutic strategy to fight cancer. Antibody recruiting molecules (ARMs) combining tumor and antibody binding modules have been developed for this purpose, however the formation of the interacting complex with both antibody and cell is difficult to optimize to stimulate immune-mediated cytotoxicity. To circumvent this limitation, we report herein a more direct approach combining cell metabolism of azido-sugar and bio-orthogonal click chemistry to conjugate at the cell glycocalyx structurally well-defined glycodendrimers as antibody binding module (ABM). We demonstrate that this strategy allows not only the recruitment of natural antibody at the surface of isolated cells or solid tumor models but also activate a cytotoxic response with human serum as unique source of immune effectors.
PMID:35211675 | PMC:PMC8792828 | DOI:10.1039/d1md00262g
24 Feb 21:01
by Alexander J. Martinko, Erin F. Simonds, Suchitra Prasad, Alberto Ponce, Colton J. Bracken, Junnian Wei, Yung-Hua Wang, Tiffany-Lynn Chow, Zhong Huang, Michael J. Evans, James A. Wells, Zachary B. Hill
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical part of modern therapeutics. These properties have been coopted in a number of synthetic formats, such as antibody–drug conjugates, bispecific antibodies, or Fc-fusion proteins to generate novel biologic drug modalities. Historically, these new therapies have...
24 Feb 21:01
by David D. Feehan
by David D. Feehan, Khusraw Jamil, Maria J. Polyak, Henry Ogbomo, Mark Hasell, Shu Shun LI, Richard F. Xiang, Michael Parkins, Joseph A. Trapani, Joe J. Harrison, Christopher H. Mody
Pseudomonas aeruginosa is an opportunistic pathogen that often infects individuals with the genetic disease cystic fibrosis, and contributes to airway blockage and loss of lung function. Natural killer (NK) cells are cytotoxic, granular lymphocytes that are part of the innate immune system. NK cell secretory granules contain the cytolytic proteins granulysin, perforin and granzymes. In addition to their cytotoxic effects on cancer and virally infected cells, NK cells have been shown to play a role in an innate defense against microbes, including bacteria. However, it is not known if NK cells kill extracellular
P.
aeruginosa or how bacterial killing might occur at the molecular level. Here we show that NK cells directly kill extracellular
P.
aeruginosa using NK effector molecules. Live cell imaging of a co-culture of YT cells, a human NK cell line, and GFP-expressing
P.
aeruginosa in the presence of the viability dye propidium iodide demonstrated that YT cell killing of
P.
aeruginosa is contact-dependent. CRISPR knockout of granulysin or perforin in YT cells had no significant effect on YT cell killing of
P.
aeruginosa. Pre-treatment of YT and NK cells with the serine protease inhibitor 3,4-dichloroisocoumarin (DCI) to inhibit all granzymes, resulted in an inhibition of killing. Although singular CRISPR knockout of granzyme B or H had no effect, knockout of both in YT cells completely abrogated killing of
P.
aeruginosa in comparison to wild type YT cell controls. Nitrocefin assays suggest that the bacterial membrane is damaged. Inhibition of killing by antioxidants suggest that ROS are required for the bactericidal mode-of-action. Taken together, these results identify that NK cells kill
P.
aeruginosa through a membrane damaging, contact-dependent process that requires granzyme induced ROS production, and moreover, that granzyme B and H are redundant in this killing process.
24 Feb 21:01
by Xingui Liu
Nature Chemical Biology, Published online: 24 February 2022; doi:10.1038/s41589-022-00978-9
Induced proximity is reshaping drug discovery. A new study debuts deubiquitinase-targeting chimeras (DUBTACs), small bifunctional molecules that co-opt a deubiquitinase to stabilize a target protein.
24 Feb 16:37
by Edward Seung
Nature, Published online: 23 February 2022; doi:10.1038/s41586-022-04439-0
A trispecific antibody targeting HER2 and T cells stimulates CD4 T cell-dependent inhibition of of breast cancer cell proliferation in vitro and tumor regression in a humanized mouse model.
24 Feb 16:36
by Eden L. Sikorski,
Janessa Wehr,
Noel J. Ferraro,
Sophia M. Rizzo,
Marcos M. Pires,
Damien Thévenin
Bifunctional immune-engaging agents that exploit the inherent acidic microenvironment of most solid tumors were developed to selectively graft the surface of cancer cells with a formyl peptide receptor ligand (FPRL). We established that selectively remodeling cancer cells with such peptides activates formyl peptide receptors on recruited immune cells, potentially initiating an immune response towards tumors.
Abstract
Current immunotherapeutics often work by directing components of the immune system to recognize biomarkers on the surface of cancer cells to generate an immune response. However, variable changes in biomarker distribution and expression can result in inconsistent patient response. The development of a more universal tumor-homing strategy has the potential to improve selectivity and extend therapy to cancers with decreased expression or absence of specific biomarkers. Here, we designed a bifunctional agent that exploits the inherent acidic microenvironment of most solid tumors to selectively graft the surface of cancer cells with a formyl peptide receptor ligand (FPRL). Our approach is based on the pH(Low) insertion peptide (pHLIP), a unique peptide that selectively targets tumors in vivo by anchoring to cancer cells in a pH-dependent manner. We establish that selectively remodeling cancer cells with a pHLIP-based FPRL activates formyl peptide receptors on recruited immune cells, potentially initiating an immune response towards tumors.
24 Feb 16:36
by Madeleine Schultz,
Rainer Müller,
Yulia Ermakova,
Jan‐Erik Hoffmann,
Carsten Schultz
A pro-drug approach delivered sulfonated and phosphonated fluorescent coumarin dyes to live cells without labeling internal membranes. The new dyes exhibited homogeneous cell distribution. In addition, the use of azide groups followed by click chemistry provided fluorogenicity.
Abstract
The delivery of small molecule fluorophores with minimal compartmentalization is currently one of the most critical technical problems in intracellular labelling. Here we introduce sulfonated and phosphonated coumarin dyes, demonstrate rapid cell entry via a prodrug approach, and show a lack of interaction with membranes, organelles, or other compartments. The dyes show no specific localization and are evenly distributed in the cells. Our fluorogenic, clickable phosphonate derivatives successfully tagged model targets in intact cells and the increase in brightness upon click reaction was around 60-fold.
22 Feb 22:35
by Ben Gold, Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood, Wasima Shinwari, Laurent Goullieux, Christine Roubert, Laurent Fraisse, Eric Bacqué, Sophie Lagrange, Bruno Filoche-Rommé, Michal Vieth, Philip A. Hipskind, Louis N. Jungheim, Jeffrey Aubé, Sarah M. Scarry, Stacey L. McDonald, Kelin Li, Andrew Perkowski, Quyen Nguyen, Véronique Dartois, Matthew Zimmerman, David B. Olsen, Katherine Young, Shilah Bonnett⧫, Douglas Joerss⧫, Tanya Parish⧫, Helena I. Boshoff, Kriti Arora, Clifton E. Barry, III, Laura Guijarro, Sara Anca, Joaquín Rullas, Beatriz Rodríguez-Salguero, Maria S. Martínez-Martínez, Esther Porras-De Francisco, Monica Cacho, David Barros-Aguirre, Paul Smith, Steven J. Berthel, Carl Nathan, and Robert H. Bates

ACS Infectious Diseases
DOI: 10.1021/acsinfecdis.1c00570
21 Feb 16:51
by Jin Zou
Front Microbiol. 2022 Feb 2;12:708580. doi: 10.3389/fmicb.2021.708580. eCollection 2021.
ABSTRACT
Bacterial persisters are a sub-population of phenotypic variants that tolerate high concentrations of antibiotics within the genetically homogeneous cells. They resume division upon the removal of drugs. Bacterial persistence is one of major causes of antibiotic treatment failure and recurrent infection. Cell dormancy, triggered by toxin/antitoxin pair, (p)ppGpp, SOS response and ATP levels, is known to be the mechanistic basis for persistence. However, recent studies have demonstrated that bacteria with active metabolism can maintain persistence by lowering intracellular antibiotic concentration via an efflux pump. Additionally, others and our work have showed that cell wall deficient bacteria (CWDB), including both L-form and spheroplasts that produced by β-lactam antibiotics, are associated with antibiotic persistence. They are not dormant cells as their cell walls have been completely damaged. In this review, we discuss the various types of persisters and highlight the contribution of non-walled bacteria on bacterial persistence.
PMID:35185807 | PMC:PMC8847742 | DOI:10.3389/fmicb.2021.708580
21 Feb 13:45
by Zachary A Morrison
16 Feb 21:27
by Zahra Rashidijahanabad, Meagan Kelly, Mohammad Kamruzzaman, Firdausi Qadri, Taufiqur R. Bhuiyan, Hunter McFall-Boegeman, Di Wu, Grzegorz Piszczek, Peng Xu, Edward T. Ryan, and Xuefei Huang⊗

ACS Infectious Diseases
DOI: 10.1021/acsinfecdis.1c00585
16 Feb 19:18
by Zachary A. Morrison, Alexander Eddenden, Adithya Shankara Subramanian, P. Lynne Howell, and Mark Nitz

ACS Chemical Biology
DOI: 10.1021/acschembio.1c00855
14 Feb 21:58
by Stephen W. Tuffs, Mariya I. Goncheva, Stacey X. Xu, Heather C. Craig, Katherine J. Kasper, Joshua Choi, Ronald S. Flannagan, Steven M. Kerfoot, David E. Heinrichs, John K. McCormick
Staphylococcus aureus is a foremost bacterial pathogen responsible for a vast array of human diseases. Staphylococcal superantigens (SAgs) constitute a family of exotoxins from S. aureus that bind directly to major histocompatibility complex (MHC) class II and T cell receptors to drive extensive T cell activation and cytokine release. Although...
11 Feb 19:03
by Ole Tietz
Nature Chemistry, Published online: 10 February 2022; doi:10.1038/s41557-021-00866-0
Reliable intracellular delivery of antibodies is one of the grand challenges in biomedical research, with the potential to address unmet clinical needs or to enable basic research. Now, it has been shown that tricyclic peptide complexes can transport functional antibodies into the cytoplasm and nucleus of cells to specifically target intracellular proteins.
10 Feb 14:52
by Adrian D. Hobson, Michael J. McPherson, Wendy Waegell, Christian A. Goess, Robert H. Stoffel, Xiang Li, Jian Zhou, Zhongyuan Wang, Yajie Yu, Axel Hernandez, Jr., Shaughn H. Bryant, Suzanne L. Mathieu, Agnieszka K. Bischoff, Julia Fitzgibbons, Martyna Pawlikowska, Sujiet Puthenveetil, Ling C. Santora, Lu Wang, Lu Wang, Christopher C. Marvin, Martin E. Hayes, Anurupa Shrestha, Kathy A. Sarris, and Biqin Li

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.1c02099
10 Feb 14:51
by Khushboo Singh, Mine Canakci, Pintu Kanjilal, Natalie Williams, Sudarvili Shanthalingam, Barbara A. Osborne, and S. Thayumanavan

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.2c00024
09 Feb 19:19
by Mohammed Rizwan Babu Sait
Sci Rep. 2022 Feb 8;12(1):2097. doi: 10.1038/s41598-022-06109-7.
ABSTRACT
The disaccharide trehalose is essential for viability of Mycobacterium tuberculosis, which synthesizes trehalose de novo but can also utilize exogenous trehalose. The mycobacterial cell wall encompasses two permeability barriers, the cytoplasmic membrane and the outer mycolic acid-containing mycomembrane. The ABC transporter LpqY-SugA-SugB-SugC has previously been demonstrated to mediate the specific uptake of trehalose across the cytoplasmic membrane. However, it is still unclear how the transport of trehalose molecules across the mycomembrane is mediated. In this study, we harnessed the antimycobacterial activity of the analogue 6-azido trehalose to select for spontaneous resistant M. tuberculosis mutants in a merodiploid strain harbouring two LpqY-SugA-SugB-SugC copies. Mutations mediating resistance to 6-azido trehalose mapped to the proline-proline-glutamate (PPE) family member PPE51 (Rv3136), which has recently been shown to be an integral mycomembrane protein involved in uptake of low-molecular weight compounds. A site-specific ppe51 gene deletion mutant of M. tuberculosis was unable to grow on trehalose as the sole carbon source. Furthermore, bioorthogonal labelling of the M. tuberculosis Δppe51 mutant incubated with 6-azido trehalose corroborated the impaired internalization. Taken together, the results indicate that the transport of trehalose and trehalose analogues across the mycomembrane of M. tuberculosis is exclusively mediated by PPE51.
PMID:35136132 | PMC:PMC8826857 | DOI:10.1038/s41598-022-06109-7
09 Feb 14:31
by Yusibeska Ramos
PLoS Pathog. 2019 Feb 11;15(2):e1007571. doi: 10.1371/journal.ppat.1007571. eCollection 2019 Feb.
ABSTRACT
Bacterial pathogens have evolved strategies that enable them to invade tissues and spread within the host. Enterococcus faecalis is a leading cause of local and disseminated multidrug-resistant hospital infections, but the molecular mechanisms used by this non-motile bacterium to penetrate surfaces and translocate through tissues remain largely unexplored. Here we present experimental evidence indicating that E. faecalis generates exopolysaccharides containing β-1,6-linked poly-N-acetylglucosamine (polyGlcNAc) as a mechanism to successfully penetrate semisolid surfaces and translocate through human epithelial cell monolayers. Genetic screening and molecular analyses of mutant strains identified glnA, rpiA and epaX as genes critically required for optimal E. faecalis penetration and translocation. Mechanistically, GlnA and RpiA cooperated to generate uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) that was utilized by EpaX to synthesize polyGlcNAc-containing polymers. Notably, exogenous supplementation with polymeric N-acetylglucosamine (PNAG) restored surface penetration by E. faecalis mutants devoid of EpaX. Our study uncovers an unexpected mechanism whereby the RpiA-GlnA-EpaX metabolic axis enables production of polyGlcNAc-containing polysaccharides that endow E. faecalis with the ability to penetrate surfaces. Hence, targeting carbohydrate metabolism or inhibiting biosynthesis of polyGlcNAc-containing exopolymers may represent a new strategy to more effectively confront enterococcal infections in the clinic.
PMID:30742693 | PMC:PMC6386517 | DOI:10.1371/journal.ppat.1007571
07 Feb 18:49
by Yu Haitao
Front Immunol. 2022 Jan 19;12:811381. doi: 10.3389/fimmu.2021.811381. eCollection 2021.
ABSTRACT
Infection caused by antibiotic-resistant microorganisms (ARMs) has been declared a global threat to public health. Polymeric nanoparticles (PNPs) formed by antimicrobial peptides (AMPs) and synthetic PNPs against ARM infections are emerging. PNPs are also considered to be a promising natural biological preservative that prevents microbial spoilage through food processing and preservation. We engineered CNMs, a novel nanocomposite antibacterial agent based on chitosan nanoparticles and AMP microcin J25. In this study, we aimed to evaluate the comprehensive antimicrobial activity, potential antimicrobial mechanism, and anti-inflammatory activity of CNMs. We demonstrated that CNMs harbor excellent bactericidal activity against clinical foodborne pathogens and ARMs. CNMs caused fast mortality against different growth phases of tetracycline (Tet)-resistant enterotoxigenic E. coli (ETEC) and significantly killed Tet-resistant ETEC in food biological environments. Mechanistically, CNMs have the ability to bind lipopolysaccharides (LPS), neutralize endotoxin, and promote diaphragm permeability by damaging the cell membrane. CNMs did not cause mouse RAW264.7 cell cytotoxicity. Notably, CNMs significantly reduced the cytotoxicity of RAW264.7 macrophages induced by LPS. The LPS-induced inflammatory response was significantly ameliorated by CNMs by reducing the levels of nitric oxide and proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-6, IL-8, IL-1β, Toll-like receptor 4, and nuclear factor κB (NF-κB), in LPS-challenged RAW264.7 macrophages. CNMs downregulated the NF-κB and mitogen-activated protein kinase signaling pathways, thereby inhibiting inflammatory responses upon LPS stimulation. Taken together, CNMs could be applied as effective antimicrobial/anti-inflammatory agents with lower cytotoxicity in food, medicine, and agriculture to prevent bacterial contamination and infection, respectively.
PMID:35126369 | PMC:PMC8807516 | DOI:10.3389/fimmu.2021.811381